BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 360938)

  • 1. Degenerative effects of various neurotoxic indoleamines on central monoamine neurons.
    Nobin A; Björklund A
    Ann N Y Acad Sci; 1978 Jun; 305():305-27. PubMed ID: 360938
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction of 5,6- and 5,7-dihydroxytryptamine with tissue monoamine oxidase.
    Klemm HP; Baumgarten HG
    Ann N Y Acad Sci; 1978 Jun; 305():36-56. PubMed ID: 280252
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of 5,6-dihydroxytryptamine and 5,7-dihydroxytryptamine on the rat central nervous system after intraventricular or intracerebral application and on blood platelets in vitro.
    Da Prada M; Pieri L; Keller HH; Pieri M; Bonetti EP
    Ann N Y Acad Sci; 1978 Jun; 305():595-620. PubMed ID: 152083
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemical lesioning of central monoamine axons by means of 5,6-dihydroxytryptamine and 5,7-dihydroxytryptamine.
    Björklund A; Baumgarten HG; Nobin A
    Adv Biochem Psychopharmacol; 1974; 10():13-33. PubMed ID: 4846535
    [No Abstract]   [Full Text] [Related]  

  • 5. Recovery of brain noradrenaline after 5,7-dihydroxytryptamine-induced axonal lesions in the rat.
    Björklund A; Baumgarten HG; Lachenmayer L; Rosengren E
    Cell Tissue Res; 1975 Aug; 161(2):145-55. PubMed ID: 1175203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De- and regeneration of brain serotonin neurons following 5,7-dihydroxytryptamine treatment: effects on serum LH, FSH and prolactin levels in male rats.
    Wuttke W; Björklund A; Baumgarten HG; Lachenmayer L; Fenske M; Klemm HP
    Brain Res; 1977 Oct; 134(2):317-31. PubMed ID: 890494
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of 5,6-dihydroxytryptamine on tyrosine-hydroxylase activity in central catecholaminergic neurons of the rat.
    Renaud B; Buda M; Lewis BD; Pujol JF
    Biochem Pharmacol; 1975 Sep; 24(18):1739-42. PubMed ID: 17
    [No Abstract]   [Full Text] [Related]  

  • 8. Degeneration of monoamine nerves in anterior byssus retractor muscle of Mytilus induced by 5,6-dihydroxytryptamine.
    Sathananthan AH
    Cell Tissue Res; 1976 Sep; 172(3):425-9. PubMed ID: 991221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical effects of dihydroxylated tryptamines on central indoleamine neurones.
    Gerson S; Baldessarini RJ; Wheeler SC
    Neuropharmacology; 1974 Nov; 13(10-11):987-1004. PubMed ID: 4280023
    [No Abstract]   [Full Text] [Related]  

  • 10. Regeneration of serotonin neurons in the rat brain after 5,6-dihydroxytryptamine-induced axotomy.
    Wiklund L; Björklund A; Nobin A
    Ann N Y Acad Sci; 1978 Jun; 305():370-84. PubMed ID: 360939
    [No Abstract]   [Full Text] [Related]  

  • 11. Reengineering the brain serotonin system: localized application of specific neurotoxins and fetal serotonergic neurons into the adult CNS.
    Azmitia EC
    Adv Neurol; 1986; 43():493-507. PubMed ID: 3484856
    [No Abstract]   [Full Text] [Related]  

  • 12. Regeneration and plasticity of central serotoninergic neurons: a review.
    Björklund A; Wiklund L; Descarries L
    J Physiol (Paris); 1981; 77(2-3):247-55. PubMed ID: 7288641
    [No Abstract]   [Full Text] [Related]  

  • 13. Dihydroxytryptamines as tools to study the neurobiology of serotonin.
    Baumgarten HG; Klemm HP; Sievers J; Schlossberger HG
    Brain Res Bull; 1982; 9(1-6):131-50. PubMed ID: 7172024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on uptake mechanisms in central monoamine neurones.
    Fuxe K; Hökfelt T; Ungerstedt U
    Acta Pharmacol Toxicol (Copenh); 1967; 25():Suppl 4:8. PubMed ID: 5630972
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of central serotonin depletion on DOCA-saline hypertension in the rat.
    Myers MG; Reid JL; Lewis PJ
    Cardiovasc Res; 1974 Nov; 8(6):806-10. PubMed ID: 4457231
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: Effects of 5,6-dihydroxytryptamine on the metabolism of 5-hydroxytryptamine in the central nervous system of the rat.
    Baldessarini RJ; Gerson S
    J Pharm Pharmacol; 1973 Aug; 25(8):647-8. PubMed ID: 4148434
    [No Abstract]   [Full Text] [Related]  

  • 17. Alterations in the neurocytotoxicity of 5,7-dihydroxytryptamine by pharmacologic agents in adult and developing rats.
    Breese GR; Mueller RA
    Ann N Y Acad Sci; 1978 Jun; 305():160-74. PubMed ID: 280248
    [No Abstract]   [Full Text] [Related]  

  • 18. Behavioral and biochemical interactions of 5,7-dihydroxytryptamine with various drugs when administered intracisternally to adult and developing rats.
    Breese GR; Cooper BR
    Brain Res; 1975 Nov; 98(3):517-27. PubMed ID: 1242372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olfactory projection systems, drugs and behaviour: a review.
    Cairncross KD; Cox B; Forster C; Wren AF
    Psychoneuroendocrinology; 1979 Jul; 4(3):253-72. PubMed ID: 515292
    [No Abstract]   [Full Text] [Related]  

  • 20. Depletion of brain serotonin following intraventricular 5,7-dihydroxytryptamine fails to disrupt sleep in the rat.
    Ross CA; Trulson ME; Jacobs BL
    Brain Res; 1976 Sep; 114(3):517-23. PubMed ID: 953773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.